Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
When a budget isn’t delivering, you need a clear plan. This guide offers actionable steps to reassess, adjust, and get back on track.
8,113 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
A fresh round of U.S. quantum funding sparked optimism in the stock market today, lifting IonQ and other quantum play...
Markets confront a familiar riddle: the buffett paradox: world’s greatest investor preaches passive investing while B...
When a stock starts gaining again today, traders watch for real catalysts behind the move. This article breaks down w...
A bold AI experiment in Argentina aimed at reshaping public policy stumbled on human error and bad data. The fallout ...
Mid-career jobseekers are trimming resumes and curating online profiles as hiring cools and AI filters tighten. The t...
Regulated XRP ETFs have opened a convenient on-ramp to Ripple exposure. This story breaks down how (ripple) beginners...
Oil markets are tight and volatile as global inventories 11-year getting tighter. This guide explains what it means f...
Markets have been rallying, but a flashing warning sign could signal trouble ahead. This guide explains what to watch...
NVIDIA stock sits at a crossroads as AI-driven demand and hyperscale spending shape a potential move toward $300. Ana...
In 2026, investors face a pivotal choice between the world's largest gold producer and a nimble challenger. This arti...
A famed Bronx Zoo elephant dies at 55, highlighting how aging animals, care costs, and donor funding shape the financ...